KDK KDK Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale at other companies

10x Genomics, Inc.TXG

$25M—

GitLabGTLB

$218.82M+33.8%

RepligenRGEN

$66M—

Fulton FinancialFULT

$35.15M+78.2%

ServisFirst BancsharesSFBS

$59.34M-27.7%

Erasca, Inc.ERAS

$58.55M+30.1%

Other financials

Income statement

See full

Revenue$1.8M+24.4%

Operating income-$37.9M-104%

Net income$26.5M+121%

EPS (diluted)$0.10+105%

Balance sheet

See full

Cash & equivalents$66.4M+247%

Total debt$58.4M+1,068%

Total equity-$245.9M+34.7%

Total assets$130.8M-76.5%

Cash flow

See full

Operating cash flow-$29.5M-78.7%

CapEx$5.5M+138%

Free cash flow-$35.0M-86.0%

Valuation

See full

Market cap$1.05B-18.6%

Enterprise value$1.04B—

P/S252.8×—

Profitability

See full

Operating margin-2,695.8%—

Net margin-10,366.9%—

FCF margin-278%—

Returns & leverage

See full

Return on equity-21.5%—

Debt / equity-0.2×—

Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: KDK’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's proceeds from maturities, prepayments and calls of debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KDK's proceeds from maturities, prepayments and calls of debt securities, available-for-sale?: KDK (KDK) reported proceeds from maturities, prepayments and calls of debt securities, available-for-sale of $45M in Q1 2026.
What does proceeds from maturities, prepayments and calls of debt securities, available-for-sale mean?: This measures cash inflows resulting from the natural maturity or early redemption of debt securities held in the investment portfolio. It indicates the recurring cash generation from the company's fixed-income investment strategy.